Business Daily

Latest Episodes:

Business Weekly: 19/12/2020 Dec 19, 2020

Show notes

On Business Weekly this week, we examine the potential big trouble for Big Tech. Regulatory bodies around the world are looking to tighten the rules that govern the digital world. Concerned by issues relating to both the web content and the business conduct of some of the big technology companies, legislators from the US to the EU are trying to re-write the digital laws. We look at what this could mean in practice for Silicon Valley. We also look at dry ice – how it works and the important role it will carry out in the distribution of the Pfizer Covid-19 vaccine, as well as the possible implications that could have for drinks industry. Plus, while Zoom business meetings are all the rage now, how long before virtual reality takes them to the next level? And we discuss the joy of traditional Christmas correspondence and find out why young people are starting to send greetings cards again. Business Weekly is presented by Lucy Burton and produced by Matthew Davies.

Cannabis in the USA: An illegal tax-paying business Dec 18, 2020

Show notes

America’s cannabis industry is worth tens of billions of dollar and it generates tax revenues and jobs. But it is barred from accessing most financial services. This is because, while legal in an increasing number US states, cannabis remains illegal at a federal level. We hear what it’s like running a cannabis business from Ken Churchill of the West Coast Cannabis Club in California. Emily Dufton, author of Grass Roots: The Rise and Fall and Rise of Marijuana in America, explains how the US went from "Just Say No" in the 1980s to yes now. And Robert Hoban, a lawyer who specialises in cannabis, explains why two currently empty Georgia Senate seats could determine whether the Biden administration can fulfil its pledge to decriminalise cannabis.

(Picture: purchasing legal marijuana at a dispensary. Credit: Getty Images.)

The monopoly case against Facebook Dec 17, 2020

Show notes

Why US regulators want to break up the social media giant. The US Federal Trade Commission (FTC) and dozens of US states are arguing that Facebook is a monopoly that harms consumers. Ed Butler speaks to tech and anti-trust researcher Dina Srinivasan about why data privacy is at the centre of the arguments over Facebook's monopoly power. Former FTC chairman Bill Kovacic explains why breaking up the social media giant is still a distant possibility. And the BBC's technology correspondent Rory Cellan-Jones discusses the rising anti-tech sentiment among both US and European regulators.

(Photo: Facebook, Whatsapp and Instagram logos. Credit: Getty Images)

Meeting in the virtual world Dec 16, 2020

Show notes

Could virtual offices provide an alternative to endless Zoom calls? Ed Bulter speaks to Jeremy Bailenson, director of Stanford University's Virtual Human Interaction Lab, about the phenomenon of 'Zoom fatigue', and why virtual reality could provide a solution. Phillip Wang, CEO of the startup Gather, shows us round his virtual office platform that combines video conferencing with old-school video game graphics. Ed tries out a meeting in virtual reality with Anand Agarawala, CEO of the VR platform Spatial. And Marc Bena from PwC explains why interest in virtual meetings is growing among businesses.

(Photo: A virtual meeting on VR platform Spatial, Credit: Spatial)

Trusting the algorithm Dec 15, 2020

Show notes

Artificial intelligence is increasingly part of our daily lives - in health, in transport, entertainment and much more - but how many of us actually trust the algorithms that drive it? Rolls-Royce says it’s now developed a system, called the Aletheia framework, that gives IT engineers in any sector a way of testing whether their AI systems are making decisions that are safe and trustworthy. The aerospace company says it's making the framework available for free to all. Manuela Saragosa speaks to Caroline Gorski from Rolls-Royce who helped develop the Aletheia framework. She also speaks about AI's trust issues with Dame Wendy Hall, Professor of Computer Science at the University of Southampton in the UK and Chair of the Ada Lovelace Institute. Plus Pag Miles from the global recruitment company Alexander Mann Solutions, explains how the Aletheia framework might help his industry which is increasingly relying on AI to select and match candidates to jobs.

Still no Brexit trade deal Dec 14, 2020

Show notes

Negotiators from the UK and EU are to begin a new push to reach agreement on post-Brexit trade after both sides agreed "to go the extra mile". A UK source said the "process still has some legs" but Boris Johnson has warned a no-deal is the "most likely" outcome. Sophie Pornschlegel, a senior policy analyst at the European Policy Centre, explains how much room there may be in Brussels' position, while the BBC's Rob Watson talks through what will be needed to get any deal over the line in the UK parliament before the 31st. And we'll hear from a UK coffee exporter, Dan Webber of Chimney Fire Coffee in Surrey, about what the prolonged uncertainty means for his business.

(Picture: Getty Images)

Business Weekly: 12/12/2020 Dec 12, 2020

Show notes

On this edition of Business Weekly, we ask whether Covid vaccines are the shot in the arm the pharmaceutical industry needs to rescue its reputation? Plus, as the world looks ahead to life after the pandemic will our transportation systems be there to help us get around? There’s a financial crisis in New York’s mass transit system. What does that mean for the city it supports? Airbnb finally packs it bags and heads to the stock market. The holiday accommodation company’s shares boomed on its first day of trading this week. We speak to Airbnb’s chief executive, Brian Chesky. Also, in China, over 15m tonnes of food is wasted every year. The government has a new plan to tackle this, but how will it convince its citizens not to throw food away? And we’ll be talking about that nine figure deal reached by Bob Dylan to sell off his back catalogue. Business Weekly is presented by Lucy Burton and produced by Matthew Davies.

Can post-Brexit Britain ban live animal exports? Dec 11, 2020

Show notes

Britain is looking to ban the export of live animals for slaughter and fattening after its existing trade arrangement with the European Union lapse at the end of this year. Natasha Smith of Compassion in World Farming, who have campaigned on this for decades, explains why they’re against the practice. Meanwhile UK minister Craig Mackinlay says leaving the EU’s trade rules after Brexit is key to getting the ban implemented. But will the ban run afoul of WTO free trade rules? Emily Rees of consultancy Trade Strategies breaks down the rules and whether the ban fits. But what do UK farmers think? Phil Stocker of the National Sheep Association says this ban overshoots, and puts farmers already in an unclear position because of Brexit, even more on the back foot. And Francesca Porta of the Brussels-based Eurogroup for Animals explains what changes might be coming in the EU itself on live animal transport.

Producer: Frey Lindsay.

(Image credit: Getty Images)

Brexit: 'Large gaps' remain after trade talks Dec 10, 2020

Show notes

Boris Johnson's dinner with EU chief Ursula von der Leyen - aimed at breaking the Brexit trade deadlock - has ended without agreement. The BBC's Laura Kuenssberg said the evening had "plainly gone badly" and the chances of the UK leaving the post-Brexit transition period at the end of the year without a firm arrangement was a "big step closer". What would that mean for the UK, and the rest of the world? Joining the programme live will be BBC World Service political correspondent Rob Watson, and Dr Anna Jerzewska, Director of the trade consultancy Trade and Borders.

Big Pharma: Vaccine Heroes or Profiteers? Dec 09, 2020

Show notes

A UK grandmother became the world’s first recipient of the Pfizer Covid vaccine this week. What does this mean for the pharmaceutical industry? This could be seen as a moment of victory for the industry, which has received a lot of bad press in the last few years. But the prices set by the vaccine makers could also provoke accusations of profiteering. We’ll hear from former Pfizer executive John Lamattina, Thomas Cueni of the International Federation of Pharmaceutical Manufacturers, Tahir Amin of the Initiative for Medicines, Access & Knowledge, as well as Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance.

(Image credit: Getty Images)

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected